Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Reckitt Benckiser’s RKT1.44%increase; green up pointing triangle shares rose after the company said adjusted profit beat ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as "non-core" in July as part of a ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

Reckitt Benckiser Group PLC hit a new 52-week high, surpassing its previous peak of £53.86, which the company achieved on ...

Reckitt Benckiser Group PLC closed 5.02% below its 52-week high of £54.18, which the company achieved on March 7th.

Berenberg analyst Fulvio Cazzol raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,920 GBp from 5,177 GBp and keeps a Hold rating ...

Barclays analyst Iain Simpson raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,600 GBp from 5,360 GBp and keeps an Equal Weight rating on the shares. See what stocks are ...

Reckitt Benckiser’s profits fell short of analysts’ expectations last year, despite burgeoning hopes of a turnaround at the consumer goods giant. The owner of brands like Strepsils, Dettol and Lemsip, ...